TMSB10 and hepatocellular carcinoma: Survival analysis, ADM2, IKBKE, IKBKE, IL11, IL15RA, PLXNA1, S100A16, TMSB10, and TOR2A were associated with poor prognosis in HCC patients (Fig. 4D).